Ten63 Therapeutics is an AI-driven drug-discovery company spun out of Duke University in 2019 and operating from San Francisco, Durham and Boston. It builds BEYOND, which the company describes as the world's first Large Quantum Chemistry Model — pairing generative chemistry at scale (Move37) with a quantum-accurate forcefield and molecular-dynamics engine (Astrolabe) in an approach it calls Superlearning. BEYOND is used to design therapeutics for previously undruggable and under-drugged targets, with an internal pipeline focused on oncology and platform partnerships such as the multi-target collaboration with Boehringer Ingelheim. Ten63 is a therapeutics company, not a software vendor: it publishes no developer program, no public API, and no machine-readable API contract. It does publish an llms.txt describing the company and platform for AI agents.
Ten63 Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Drug Discovery, and Artificial Intelligence.
Ten63 Therapeutics’ developer surface includes support and 4 more developer resources.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
aid: ten63-therapeutics
name: Ten63 Therapeutics
description: 'Ten63 Therapeutics is an AI-driven drug-discovery company spun out of Duke University in 2019 and operating
from San Francisco, Durham and Boston. It builds BEYOND, which the company describes as the world''s first Large Quantum
Chemistry Model — pairing generative chemistry at scale (Move37) with a quantum-accurate forcefield and molecular-dynamics
engine (Astrolabe) in an approach it calls Superlearning. BEYOND is used to design therapeutics for previously undruggable
and under-drugged targets, with an internal pipeline focused on oncology and platform partnerships such as the multi-target
collaboration with Boehringer Ingelheim. Ten63 is a therapeutics company, not a software vendor: it publishes no developer
program, no public API, and no machine-readable API contract. It does publish an llms.txt describing the company and platform
for AI agents.'
url: https://raw.githubusercontent.com/api-evangelist/ten63-therapeutics/refs/heads/main/apis.yml
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
source:
- security
generated: '2026-09-02'
method: derived
image: https://www.ten63tx.com/brand/White.webp
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-30'
modified: '2026-08-30'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Drug Discovery
- Artificial Intelligence
- Machine Learning
- Computational Chemistry
- Oncology
- Life Sciences
- Research
tags_raw:
- Company
- Biotechnology
- Pharmaceuticals
- Drug Discovery
- Artificial Intelligence
- Machine Learning
- Computational Chemistry
- Oncology
- Life Sciences
- Research
- Machine-Learning
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: DomainSecurity
url: security/ten63-therapeutics-domain-security.yml
- type: Website
url: https://www.ten63tx.com/
- type: Support
url: https://www.ten63tx.com/contact
- type: GitHubOrganization
url: https://github.com/ten63tx
- type: LLMsTxt
url: llms/ten63-therapeutics-llms.txt
x-enrichment:
date: '2026-08-30'
status: minimal
artifacts_added: 3
pass: local-v1
x-coverage:
state: none
reason: no-developer-program
detail: Ten63 Therapeutics is a clinical-stage drug-design company, not a software vendor — its BEYOND Large Quantum Chemistry
Model is run internally and licensed through pharma partnerships, and www.ten63tx.com is a two-page marketing site whose
own sitemap.xml lists only the home page and /contact, with no developer portal, docs, SDK or spec anywhere on it.
evidence:
- url: https://www.ten63tx.com/sitemap.xml
status: 200
- url: https://www.ten63tx.com/openapi.json
status: 404
- url: https://www.ten63tx.com/docs
status: 404
- url: https://www.ten63tx.com/.well-known/agent-card.json
status: 404
- url: https://api.github.com/orgs/ten63tx
status: 200
- url: https://www.ten63tx.com/llms.txt
status: 200
checked: '2026-08-30'
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.